Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of Intravitreal Microplasmin in Relieving Vitreo-Macular Adhesion in Neovascular Age-related Macular Degeneration (AMD)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified September 2011 by University of California, Los Angeles.
Recruitment status was:  Recruiting
Sponsor:
Collaborator:
ThromboGenics
Information provided by (Responsible Party):
Steven Schwartz, University of California, Los Angeles
ClinicalTrials.gov Identifier:
NCT00996684
First received: October 15, 2009
Last updated: September 26, 2011
Last verified: September 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2011
  Estimated Primary Completion Date: September 2011 (Final data collection date for primary outcome measure)